28
Participants
Start Date
August 31, 2015
Primary Completion Date
October 31, 2015
Study Completion Date
April 30, 2016
15 mg E4/3 mg DRSP
All subjects received both Treatment A and Treatment B either at the first treatment period (Period 1) or the second treatment period (Period 2). Approximately half of the subjects was randomized to receive either Treatment A followed by Treatment B (Sequence AB), or Treatment B followed by Treatment A (Sequence BA)
Lead Sponsor
Estetra
INDUSTRY